AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionMonetary Management Group Inc
Latest Disclosed Ownership34,230 shares
Latest Disclosed Value $ 7,444,683
Monetary Management Group Inc ownership in 4AB / AbbVie Inc.

On May 13, 2026 - Monetary Management Group Inc filed a 13F-HR form disclosing ownership of 34,230 shares of AbbVie Inc. (BG:4AB) valued at $7,444,683 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 34,230 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Abbvie Inc Com COM 00287Y109 34,230 0 0.00 7,445 -4.82 1.7780
2026-02-11 2025-12-31 13F Abbvie lnc. COM 00287Y109 34,230 -1,135 -3.21 7,821 -4.48 1.8084
2025-11-12 2025-09-30 13F Abbvie lnc. COM 00287Y109 35,365 -1,000 -2.75 8,188 21.30 1.8801
2025-08-14 2025-06-30 13F Abbvie lnc. COM 00287Y109 36,365 -50 -0.14 6,750 -11.52 1.6614
2025-05-14 2025-03-31 13F Abbvie lnc. COM 00287Y109 36,415 -200 -0.55 7,630 17.26 2.0618
2025-02-13 2024-12-31 13F Abbvie lnc. COM 00287Y109 36,615 100 0.27 6,506 -9.76 1.6907
2024-11-13 2024-09-30 13F Abbvie lnc. COM 00287Y109 36,515 -1,150 -3.05 7,211 11.61 1.8532
2024-07-16 2024-06-30 13F Abbvie lnc. COM 00287Y109 37,665 384 1.03 6,460 -4.83 1.7080
2024-05-13 2024-03-31 13F Abbvie lnc. COM 00287Y109 37,281 -434 -1.15 6,789 16.15 1.8914
2024-02-14 2023-12-31 13F Abbvie COM 00287Y109 37,715 260 0.69 5,845 4.67 1.8230
2023-11-09 2023-09-30 13F Abbvie COM 00287Y109 37,455 -6,850 -15.46 5,583 -6.47 1.8610
2023-08-11 2023-06-30 13F Abbvie COM 00287Y109 44,305 -5,725 -11.44 5,969 -25.13 1.8293
2023-05-11 2023-03-31 13F Abbvie COM 00287Y109 50,030 675 1.37 7,973 -0.04 2.3462
2023-02-13 2022-12-31 13F Abbvie COM 00287Y109 49,355 -1,375 -2.71 7,976 17.16 2.4907
2022-11-14 2022-09-30 13F Abbvie COM 00287Y109 50,730 -350 -0.69 6,808 -12.97 2.2438
2022-08-11 2022-06-30 13F Abbvie COM 00287Y109 51,080 -500 -0.97 7,823 -6.45 2.4523
2022-05-12 2022-03-31 13F Abbvie COM 00287Y109 51,580 -500 -0.96 8,362 18.58 2.2149
2022-02-14 2021-12-31 13F Abbvie COM 00287Y109 52,080 2,800 5.68 7,052 32.66 1.7447
2021-11-12 2021-09-30 13F Abbvie COM 00287Y109 49,280 5,450 12.43 5,316 7.68 1.4618
2021-08-12 2021-06-30 13F Abbvie COM 00287Y109 43,830 -50 -0.11 4,937 3.96 1.4879
2021-05-17 2021-03-31 13F Abbvie COM 00287Y109 43,880 -1,825 -3.99 4,749 -3.02 1.4937
2021-02-12 2020-12-31 13F Abbvie COM 00287Y109 45,705 -150 -0.33 4,897 21.94 1.6136
2020-11-12 2020-09-30 13F Abbvie COM 00287Y109 45,855 -1,375 -2.91 4,016 -13.39 1.4308
2020-08-13 2020-06-30 13F Abbvie COM 00287Y109 47,230 -270 -0.57 4,637 28.13 1.7523
2020-05-14 2020-03-31 13F Abbvie COM 00287Y109 47,500 4,800 11.24 3,619 -4.28 1.6016
2020-02-13 2019-12-31 13F Abbvie COM 00287Y109 42,700 -1,885 -4.23 3,781 12.00 1.3819
2019-11-12 2019-09-30 13F Abbvie COM 00287Y109 44,585 8,170 22.44 3,376 27.49 1.2781
2019-08-13 2019-06-30 13F Abbvie COM 00287Y109 36,415 575 1.60 2,648 -8.31 1.0169
2019-05-14 2019-03-31 13F Abbvie COM 00287Y109 35,840 0 0.00 2,888 -12.59 1.1433
2019-02-13 2018-12-31 13F Abbvie COM 00287Y109 35,840 -125 -0.35 3,304 -2.88 1.4929
2018-11-13 2018-09-30 13F Abbvie COM 00287Y109 35,965 -5,810 -13.91 3,402 -12.09 1.2993
2018-08-13 2018-06-30 13F Abbvie COM 00287Y109 41,775 -350 -0.83 3,870 -2.93 1.5788
2018-05-14 2018-03-31 13F Abbvie COM 00287Y109 42,125 -375 -0.88 3,987 -2.99 1.6528
2018-02-14 2017-12-31 13F Abbvie COM 00287Y109 42,500 -200 -0.47 4,110 8.33 1.6563
2017-11-13 2017-09-30 13F Abbvie COM 00287Y109 42,700 -3,200 -6.97 3,794 14.00 1.5996
2017-08-14 2017-06-30 13F Abbvie COM 00287Y109 45,900 -50 -0.11 3,328 11.16 1.3600
2017-05-15 2017-03-31 13F Abbvie COM 00287Y109 45,950 425 0.93 2,994 5.02 1.3018
2017-02-13 2016-12-31 13F Abbvie COM 00287Y109 45,525 75 0.17 2,851 -0.56 1.3172
2016-11-10 2016-09-30 13F Abbvie COM 00287Y109 45,450 -575 -1.25 2,867 0.63 1.3263
2016-08-12 2016-06-30 13F Abbvie COM 00287Y109 46,025 177 0.39 2,849 8.78 1.3254
2016-05-11 2016-03-31 13F Abbvie COM 00287Y109 45,848 0 0.00 2,619 -3.57 1.2733
2016-02-11 2015-12-31 13F Abbvie COM 00287Y109 45,848 200 0.44 2,716 9.34 1.3007
2015-11-25 2015-09-30 13F Abbvie COM 00287Y109 45,648 -2,000 -4.20 2,484 -22.40 1.2426
2015-08-11 2015-06-30 13F Abbvie COM 00287Y109 47,648 1,675 3.64 3,201 18.95 1.4438
2015-05-12 2015-03-31 13F Abbvie COM 00287Y109 45,973 9,200 25.02 2,691 11.85 1.1876
2015-02-12 2014-12-31 13F Abbvie COM 00287Y109 36,773 9,025 32.52 2,406 50.09 1.0685
2014-11-06 2014-09-30 13F Abbvie COM 00287Y109 27,748 3,600 14.91 1,603 17.61 0.7430
2014-08-12 2014-06-30 13F Abbvie COM 00287Y109 24,148 4,900 25.46 1,363 37.82 0.6377
2014-05-08 2014-03-31 13F Abbvie COM 00287Y109 19,248 -19,875 -50.80 989 -52.13 0.4600
2014-02-14 2013-12-31 13F Abbvie COM 00287Y109 39,123 250 0.64 2,066 18.80 0.9574
2013-11-12 2013-09-30 13F Abbvie COM 00287Y109 38,873 0 0.00 1,739 8.21 0.9140
2013-08-14 2013-06-30 13F Abbvie COM 00287Y109 38,873 38,873 1,607 0.8798
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.